These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16572133)

  • 1. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 2. US Supreme Court decision could compromise biotech patents.
    Robertson D
    Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US Supreme Court applies strict limits to patents.
    Robertson D
    Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
    [No Abstract]   [Full Text] [Related]  

  • 5. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent US patent legislation: what's new for biotech?
    Gogoris AC; Todaro JC
    Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 9. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 10. It's all about cures and cash. How the winner of the race to patent human genes may strike it rich.
    Sherrid P
    US News World Rep; 2001 Jan; 130(1):35-6. PubMed ID: 11189705
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 12. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 14. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent reform prompts intellectual tug-of-war.
    Nature; 2005 Oct; 437(7063):1230-1. PubMed ID: 16251923
    [No Abstract]   [Full Text] [Related]  

  • 16. Collaborative research presents special problems for patent seekers.
    Thorne LW; Ergenzinger ER; Spruill WM
    Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550
    [No Abstract]   [Full Text] [Related]  

  • 17. Negotiating the RNAi patent thicket.
    Schmidt C
    Nat Biotechnol; 2007 Mar; 25(3):273-5. PubMed ID: 17344871
    [No Abstract]   [Full Text] [Related]  

  • 18. The scope of utility in the twenty-first century: new guidance for gene-related patents.
    Summers TM
    Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
    [No Abstract]   [Full Text] [Related]  

  • 19. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 20. The new section 103(b) of the patent law: an obvious solution?
    Van Horn CE; Barlow SA
    Nat Biotechnol; 1996 Jun; 14(6):773-4. PubMed ID: 9630989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.